Studying the Expected Effect of Ivermectin Nanosuspension as Nasal Spray Upon Post covid19 Persistant Anosmia
试验速览
- 阶段
- 2 期
- 入组人数
- 117
- 试验地点
- 1
- 主要终点
- regaining of smell
研究概览
简要总结
ivermectin is FDA approaved antiparasitic drug which is also claimed to be having potent in vitro antiviral effect,so we are tryying to study itsovid19 anosmia effect upon releiving post covid19 anosmia
详细描述
ivermectin is FDA approaved antiparasitic drug which is also claimed to be having potent in vitro antiviral effect,so we are tryying to study itsovid19 anosmia effect upon releiving post covid19 anosmia as one of the most characteresic symptoms of covid19 infection
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 70 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •post covid19 anosmia
- •negative swab test for covid19
排除标准
- •other types of anosmia ,
- •no local or central other causes of anosmia
- •still active covid 19 pateints ( positive swab test )
研究组 & 干预措施
intranasal Ivermectin group
49 pateints with anosmia received ivermectin nanosuspension nasal spray
干预措施: intranasal spray ivermectin (Drug)
saline nasal spray
47 pateints with anosmia received saline nasal spray
干预措施: intranasal spray ivermectin (Drug)
结局指标
主要结局
regaining of smell
时间窗: within 14 days after enrollemen ]
regaining of smell
次要结局
未报告次要终点
研究者
Zaky Aref
ass.professor
South Valley University